IPH announces 52 promotions for 2024

10 July 2024

Leading international intellectual property services group, IPH, is proud to announce 52 promotions, including five Principal appointments, across its member firms AJ Park, Griffith Hack, Pizzeys, ROBIC, Smart & Biggar and Spruson & Ferguson. This is a record number of promotions for the group in recent years, doubling the number appointed in 2023.  

Promotions have been made across a range of practice areas, recognising professionals across 14 offices in seven of the group’s ten IP jurisdictions and servicing clients in more than 25 countries, a testament to the global growth of the IPH group.  

Dr Andrew Blattman, IPH Managing Director and CEO, said “At IPH we take great pride in uplifting our people and ensuring that talented individuals are recognised and empowered with the tools to build their skills and grow their career. 

“As an international network of firms, IPH is committed to supporting and developing people at all levels and areas of our work. Being promoted is a significant milestone and a testament to the talent and hard work of an individual, and I’m thrilled to see so many of our people be recognised in this way.” 

“Congratulations to this year’s promoted staff.”  

IPH employs more than 1,600 people working in Australia, Canada, China, Hong Kong SAR, Indonesia, Malaysia, New Zealand, Philippines, Singapore and Thailand. 

2024 Principal Promotions

ROBIC

  • Amélie Côté, Principal, Legal
  • Marine Keraron, Principal, EICT

Smart & Biggar

  • David Walters, Principal, EICT

Spruson & Ferguson Asia

  • Kua Han Chun, Principal, EICT

Spruson & Ferguson Australia

  • Jason Manakis, Principal, EICT

     

Additional 2024 Promotions

AJ Park

  • Dr Victoria Argyle, Special Counsel, Law
  • Dr Briar Dominick, Senior Associate, Chembio
  • Rachel McIvor, Senior Associate, Chembio
  • Dominic Scott-Jones, Associate, Law

Griffith Hack

  • Simon Gapes, Special Counsel, Trade Marks
  • Dr Megan Cole, Associate, ChemLife
  • Dr Radhika Moore, Associate, EICT
  • Dr Arun Nagasubramanian, Associate, EICT

Pizzeys

  • Pulari Thangavelu, Associate, ChemLife

ROBIC

  • Tara D’aigle-Curley, Senior Lawyer, Legal
  • Jules Gaudin, Senior Lawyer, Legal
  • Fortunat Nadima Nadima, Senior Lawyer, Litigation
  • Cara Parisien, Senior Lawyer, Litigation
  • Catherine Thall Dubé, Senior Lawyer, Litigation
  • Michel Bélanger, Senior Patent Agent, Life Sciences
  • Laurence Bourget-Merle, Senior Patent Agent, Life Sciences
  • Laurence Danis, Senior Patent Agent, Life Sciences
  • Stacey Dunn, Senior Patent Agent, EICT
  • Michel Dussault, Senior Patent Agent, EICT
  • Jean-François Journault, Senior Patent Agent, EICT
  • Michael Ionescu, Senior Patent Agent, EICT
  • David Salem, Senior Patent Agent, Life Sciences
  • Karine Pommier, Senior Trademark Agent, Trademark

Smart & Biggar

  • Michael Sgro, Senior Associate, Life Science
  • Matthew Norton, Senior Associate, Litigation
  • Olivier Jean-Lévesque, Senior Associate, Trademarks
  • Nora Labbancz, Senior Associate, Trademarks
  • Tierney Deluzio, Senior Associate, Trademarks

Spruson & Ferguson Asia

  • Dr Vivian Wang, Special Counsel, CLS
  • Dr Michael Huang, Special Counsel, CLS
  • Patsita Issareeworatit, Senior Associate, Trade Marks
  • Thanchanok Pankrai, Associate, CLS
  • Piyamin Sepacha, Associate, CLS

Spruson & Ferguson Australia

  • Stuart Hughes, Special Counsel, Legal
  • Dr David Hvasanov, Special Counsel, CLS
  • Dr Ken Johnstone, Special Counsel, CLS
  • Dr Matthew Stewart, Special Counsel, CLS
  • Dr Jon Wright, Special Counsel, CLS
  • Lan Pham, Senior Associate, Trade Marks
  • Chelsea Peters, Senior Associate, Trade Marks
  • Chi Pu, Senior Associate, EICT
  • Danielle Spath, Senior Associate, Trade Marks
  • Steven Banos, Associate, Trade Marks
  • Dr James Beckett, Associate, CLS
  • Madeline Connolly, Associate, Trade Marks
  • Peter Matalanis, Associate, EICT
  • Dr Yuchen Yao, Associate, CLS
IMPORTANT NOTICE

The information on this page is not part of the Prospectus.

If you agree to the conditions on this page, you will be given access to an electronic version of the Offer Document.

Before downloading, printing or viewing any of the documents on this website, you must carefully read the terms set out in this notice.

The Offer Document (defined below) is an important document that should be read in its entirety before deciding whether to participate in the Offer (as referred to below and set out in the Offer Document). You should rely only on information in the Offer Document and any supplementary or replacement document. If after reading the Offer Document, you have questions about the Offer, you should contact your professional advisers. You can contact the IPH Offer Information Line on 1300 653 497 from 8.30am until 5.30pm (AEDT) Monday to Friday for further information.

Offer of Securities

The Offer Document contains details of an offer (“Offer”) by IPH Limited ACN 169 015 838 (“IPH” or “Company”) and IPH (SaleCo) Pty Limited ACN 600 396 825 of fully paid ordinary shares (“Shares” or "Securities”) in IPH. IPH applied to ASX Limited (“ASX”) within seven days after the date of the Offer Document for quotation of Securities on ASX.

Lodgement of the Offer Document

The prospectus accessible on this website is dated 9 October 2014 (“Offer Document”, or “Prospectus”) and was lodged with the Australian Securities and Investments Commission (“ASIC”) on that date. Capitalised words used on this website have the meaning given to them in the Offer Document unless they are defined with a different meaning on this website. Neither ASIC nor the ASX takes any responsibility for the content of the Prospectus or for the merits of the investment to which the Prospectus relates.

Applications for Securities

Applications to subscribe for Securities under the Offer may only be made using an Application Form issued with, contained in, or accompanying the Offer Document. Securities will only be issued or transferred on the basis of an Application Form. An Application Form is accessible in the following ways:
  • by viewing the Offer Document from this website and then printing the Application Form attached to it; or
  • by way of a paper copy of the Application Form issued with, contained in, or accompanying a paper copy of the Offer Document. A paper copy of the Offer Document (with Application Form) and any supplementary or replacement document, can be requested and will be provided free of charge, by calling the IPH Offer Information Line on 1300 653 497 (within Australia) or +61 1300 653 497 (outside Australia) from 8.30am until 5.30pm AEDT Monday to Friday during the Offer period.
You must complete your Application Form and pay your application monies in accordance with your Broker’s directions in order to be eligible to receive any allocation from your Broker. Please contact your Broker if you have any questions on how to complete the Application Form. You should read the Offer Document in full before submitting your Application Form.

The Corporations Act 2001 (Cth) prohibits any person from passing onto another person an Application Form in relation to the Offer unless it is attached to, or accompanied by, a complete and unaltered copy of the Offer Document.

Warning – This information does not constitute an Offer of Securities

The documents on this website are only available to residents of Australia and New Zealand from within Australia and New Zealand. None of the documents on this website (including the Offer Document) constitutes an offer of securities for sale in any jurisdiction in which, or to any person to whom, it would not be lawful to make such an offer. In particular, the documents on this website (including the Offer Document) are not an offer of securities for sale in the United States or to, or for the account or benefit of, persons in the United States (as defined in Regulation S under the United States Securities Act of 1933 (the “US Securities Act”)). The Shares in the Offer may not be offered, sold or otherwise transferred, except in compliance with the registration requirements of the US Securities Act, and any other applicable securities laws or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and any other applicable securities laws. The Shares in the Offer have not been and will not be registered under the US Securities Act or the securities laws of any state of the United States or any other jurisdiction other than Australia and New Zealand.

No action has been taken to register or qualify the documents on this website, the Offer or Securities, in any jurisdiction other than Australia and New Zealand. The distribution of the documents on this website (including the Offer Document) outside Australia and New Zealand is restricted by law. You should inform yourself of and observe such restrictions and should seek your own advice on such restrictions. Any non-compliance with these restrictions may contravene applicable securities laws.

Changes

The information on this website is provided for information purposes only and subject to change without notice. Nothing contained on this website or in the Offer Document constitutes investment, legal, business, taxation or other advice, nor is it to be relied on in making an investment in Securities. The information on this website and in the Offer Document does not take into account your investment objectives, financial situation or particular needs.

Terms and conditions

By continuing you represent, warrant and agree that:
  • you have read, understood and will comply with the notice on this website;
  • you are a resident of Australia or New Zealand accessing this website from Australia or New Zealand;
  • you are not in the United States and you are not acting for the account or benefit of a person in the United States;
  • you will not make a copy of the documents in this website available to, or release or distribute a copy of such documents to, or for the account or benefit of, any person in the United States or in any other place in which, or to any other person to whom, it would be unlawful to do so ("Ineligible Persons");
  • you are not acting as a nominee for, or otherwise for the account or benefit of, any Ineligible Persons; and
  • you and each person on whose account you are acting acknowledge that the securities described on the following pages have not been and will not be, registered under the US Securities Act of 1933, as amended, or the securities laws of any state or other jurisdiction in the United States and accordingly, the securities may not be offered, sold or otherwise transferred except in accordance with an available exemption from such registration.